Copanlisib Intravenous and Hepatic impairment
Result of checking the interaction of drug Copanlisib Intravenous and disease Hepatic impairment for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Copanlisib is primarily metabolize by the liver. Based on the population pharmacokinetic analysis, no clinically relevant difference was observed in patients with mild hepatic impairment. The pharmacokinetics of copanlisib have not been evaluated in patients with moderate to severe hepatic impairment. Close monitoring is recommended in these patients.
Generic Name: copanlisib
Brand Name: Aliqopa
Synonyms: Copanlisib